No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls
- 30 June 2011
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 25 (2-3) , 134-136
- https://doi.org/10.1016/j.mcp.2011.01.005
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- XMRV Infection in Patients With Prostate Cancer: Novel Serologic Assay and Correlation With PCR and FISHUrology, 2010
- Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patientsRetrovirology, 2009
- XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumorsProceedings of the National Academy of Sciences, 2009
- An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumorsProceedings of the National Academy of Sciences, 2007
- Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL VariantPLoS Pathogens, 2006
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Effect of Long-Term Freezer Storage, Thawing, and Refreezing on Selected Constituents of SerumMayo Clinic Proceedings, 1989